Atria Wealth Solutions Inc. Purchases 1,000 Shares of The Cigna Group (NYSE:CI)

Atria Wealth Solutions Inc. grew its position in shares of The Cigna Group (NYSE:CIFree Report) by 16.1% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned 7,224 shares of the health services provider’s stock after acquiring an additional 1,000 shares during the quarter. Atria Wealth Solutions Inc.’s holdings in The Cigna Group were worth $1,995,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. AMF Tjanstepension AB raised its holdings in The Cigna Group by 18.6% in the 3rd quarter. AMF Tjanstepension AB now owns 73,600 shares of the health services provider’s stock worth $25,511,000 after purchasing an additional 11,550 shares during the period. Swedbank AB raised its holdings in The Cigna Group by 26.6% in the 3rd quarter. Swedbank AB now owns 570,283 shares of the health services provider’s stock worth $197,569,000 after purchasing an additional 119,681 shares during the period. International Assets Investment Management LLC raised its holdings in The Cigna Group by 49,287.7% in the 3rd quarter. International Assets Investment Management LLC now owns 400,040 shares of the health services provider’s stock worth $138,590,000 after purchasing an additional 399,230 shares during the period. Mount Yale Investment Advisors LLC raised its holdings in The Cigna Group by 2.5% in the 3rd quarter. Mount Yale Investment Advisors LLC now owns 1,733 shares of the health services provider’s stock worth $600,000 after purchasing an additional 42 shares during the period. Finally, Ballentine Partners LLC raised its holdings in The Cigna Group by 9.8% in the 3rd quarter. Ballentine Partners LLC now owns 7,726 shares of the health services provider’s stock worth $2,677,000 after purchasing an additional 691 shares during the period. 86.99% of the stock is owned by institutional investors.

The Cigna Group Trading Up 0.1 %

CI opened at $299.92 on Friday. The firm has a market cap of $83.42 billion, a P/E ratio of 24.50, a P/E/G ratio of 0.98 and a beta of 0.54. The Cigna Group has a 12 month low of $262.03 and a 12 month high of $370.83. The company has a current ratio of 0.66, a quick ratio of 0.72 and a debt-to-equity ratio of 0.70. The stock has a 50-day moving average of $286.35 and a 200 day moving average of $319.54.

The Cigna Group (NYSE:CIGet Free Report) last announced its earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same period in the previous year, the business posted $6.79 EPS. As a group, research analysts forecast that The Cigna Group will post 29.77 EPS for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Stockholders of record on Wednesday, March 5th will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a dividend yield of 2.01%. The ex-dividend date of this dividend is Wednesday, March 5th. This is an increase from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is currently 45.75%.

Analysts Set New Price Targets

A number of brokerages recently commented on CI. Royal Bank of Canada set a $355.00 target price on The Cigna Group in a report on Friday, January 31st. Stephens decreased their price target on The Cigna Group from $410.00 to $380.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. StockNews.com raised The Cigna Group from a “hold” rating to a “buy” rating in a report on Wednesday. Barclays decreased their price target on The Cigna Group from $420.00 to $339.00 and set an “overweight” rating on the stock in a report on Friday, January 31st. Finally, Raymond James reissued a “strong-buy” rating and set a $360.00 price target (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Two research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $372.31.

Get Our Latest Report on The Cigna Group

About The Cigna Group

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.